Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-17
SponsorAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

About this trial

This multicenter prospective observational non-pharmacological study aims to evaluate resting energy expenditure (REE) in pediatric patients affected by inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. REE will be measured using indirect calorimetry and estimated using predictive equations. The study also aims to investigate the relationship between REE, disease activity, and dietary or pharmacological treatments. Clinical, laboratory, anthropometric, nutritional, and disease activity data will be collected during routine clinical follow-up at diagnosis, after induction therapy, and during follow-up visits.

Eligibility criteria

Qualifiers

Pediatric patients aged 6 to 17 years

New diagnosis of inflammatory bowel disease, including Crohn disease or ulcerative colitis, according to ECCO/ESPGHAN criteria

Written informed consent signed by parents or legal guardians

Disqualifiers

Intestinal surgery within 6 weeks before the first evaluation

Parenteral or enteral nutrition within 6 weeks before the first evaluation

Eating disorders or other chronic diseases associated with possible malabsorption

Trial design

Treatments tested in this trial

  • Indirect Calorimetry

Treatment groups

50 Participants
are divided into 1 treatment group